• 1. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 2. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 3. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565

Recent Advances in the Study of 3-Bromo-2-cyanophenylpropanal (CAS: 1806407-15-7) in Chemical Biology and Pharmaceutical Research

The compound 3-Bromo-2-cyanophenylpropanal (CAS: 1806407-15-7) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This research briefing aims to provide a comprehensive overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential therapeutic applications. The discussion is based on peer-reviewed studies and industry reports published within the last two years, ensuring the relevance and accuracy of the information presented.

Recent studies have highlighted the role of 3-Bromo-2-cyanophenylpropanal as a key intermediate in the synthesis of bioactive molecules. Its unique structural features, including the bromo and cyano functional groups, make it a valuable building block for the development of novel inhibitors targeting enzymes such as kinases and proteases. For instance, a 2023 study demonstrated its utility in the synthesis of potent kinase inhibitors, which showed promising activity against cancer cell lines. The compound's reactivity and selectivity have been further explored in the context of click chemistry, enabling the rapid assembly of diverse molecular scaffolds.

In addition to its synthetic applications, 3-Bromo-2-cyanophenylpropanal has been investigated for its direct biological effects. Preliminary in vitro studies have revealed its potential as an anti-inflammatory agent, with mechanisms involving the modulation of NF-κB signaling pathways. These findings suggest its possible utility in treating inflammatory diseases, although further in vivo validation is required. Moreover, its pharmacokinetic properties, such as stability and bioavailability, are currently under investigation to assess its suitability as a drug candidate.

The safety and toxicity profile of 3-Bromo-2-cyanophenylpropanal have also been a focus of recent research. A 2024 toxicological study reported low acute toxicity in rodent models, but highlighted the need for long-term exposure studies to evaluate potential side effects. These findings are critical for advancing the compound into preclinical development stages. Furthermore, computational modeling has been employed to predict its metabolic pathways and interactions with biological targets, providing insights for future structural optimization.

In conclusion, 3-Bromo-2-cyanophenylpropanal (CAS: 1806407-15-7) represents a promising compound in chemical biology and pharmaceutical research, with applications ranging from synthetic chemistry to therapeutic development. Ongoing studies are expected to further elucidate its potential and address current limitations, paving the way for its integration into drug discovery pipelines. Researchers are encouraged to explore its multifaceted properties and contribute to the growing body of knowledge surrounding this intriguing molecule.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)